Prof. Linda Griffith received her BS in from Georgia Tech (1982) and her PhD from UC Berkeley (1988), both in Chemical Engineering. She is currently the School of Engineering Professor of Teaching Innovation in Biological Engineering at the Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research. She is currently the School of Engineering Professor of Teaching Innovation in Biological Engineering at the Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research. She is a member of the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, the American Academy of Arts and Sciences, a MacArthur Foundation Fellow, and has received numerous other awards from professional societies and from MIT.

Amélie Moreau defended her PhD in molecular biology, dealing with the detoxication process and crosstalks occurring with other physiologic pathways within Prof. Patrick Maurel’s laboratory in Montpellier (France, INSERM). She then joined Prof. Olivier Fardel’s team in Rennes (France, INSERM) where she explored deeper drug transporters functioning. Her experience in drug–drug interactions and in vitro pharmacokinetics in Servier DMPK’s team help her to have a great overview of the different ways to explore drug fate in the human body.

Dr Audrey Dubourg is CN Bio’s Product Manager for the PhysioMimix® OOC range of microphysiological systems. Prior to joining CN Bio, she worked as a postdoctoral scholar at the University of California – Los Angeles (UCLA), in the US, in the Microbiology, Immunology and Molecular Genetics department. She completed an MSc in microbiology at the University of Montpellier II, followed by a PhD in microbiology/parasitology at the University of East Anglia. Audrey has extensive experience in the disciplines of molecular biology and 3D mammalian cell culture. Since joining CN Bio, she has been actively involved in promoting the benefits of incorporating organ-on-a-chip technology into drug discovery and development workflows.

Dr. Yassen Abbas is a Lead Scientist at CN Bio. He completed an MEng in chemical engineering at The University of Edinburgh and joined the European Space Agency as a graduate engineer. He later received a PhD from the University of Cambridge and completed a postdoc fellowship, also at Cambridge on the development of a tissue engineered model of the human endometrium. He has experience with real-time sensor technology, organoids and development of in vitro tissue models using human primary cells. Dr Abbas has published five peer-reviewed scientific articles, four as first author.